Report an error

Spotted something inaccurate in “GLP-1 Drugs Associated With 14% Lower Heart Risk Than SGLT2 Inhibitors in Real-World MASLD Study”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.